Background Rift Valley fever is a viral epidemic illness prevalent in Africa that can be fatal or
result in debilitating sequelae in humans. No vaccines are available for human use. We …

… Here, we report the results of an open label, non-… vaccination with different commonly used
flavivirus vaccines. Healthy study participants were enrolled into cohorts receiving vaccines …

… administration of two recommended routine pediatric vaccines. Since fever is an important
issue with vaccine tolerability, we performed this open-label study on the efficacy and safety of …

… recommended to allay concerns of high fever and febrile convulsion. We … at vaccination on
infant febrile reaction rates and vaccine … Fever is also a well described event after vaccination. …

… This paper reports results of a large, randomized, controlled, open-label trial examining
effects of coadministration or delayed administration (ie, dose timing) of paracetamol or …

… -prequalified yellow fever vaccines for the general adult population and fills a crucial
knowledge gap to support WHO policy on the use of fractional dosing of yellow fever vaccine for …

… also included an open label ibuprofen arm (3:3:2). The ibuprofen arm was smaller, as it
was added to obtain preliminary data on immunogenicity effects, and was open-label as the …

… prevention of Lassa fever. To our knowledge, this study presents the first clinical data on a
Lassa fever vaccine candidate. We show that this measles-vector-based vaccine candidate (…

… fever vaccination as an off-label use in response to emergency situations where current
vaccine … vaccine batch, the stock available and the suitability of injection devices. The minimal …

… In this study, 10 mo after yellow fever vaccination, only a small number of volunteers had
seroconverted to dengue, most probably due to the disease itself. Moreover, differences in …